← Eichor
Study identifier: NCT06142656 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome

Condition: Poly Cystic Ovary Syndrome  ·  Sponsor: October 6 University

PhasePhase 2/Phase 3
Planned participants60
Who can joinFemale, 18 Years to 50 Years
Healthy volunteersNo

About this study

Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects approximately 10-20% of women of reproductive age, Management strategies for PCOS include lifestyle modifications such as diet and physical activity that are the first-line approach to treatment; however, they are reported to be minimally effective in reducing weight or treating PCOS-related symptoms.Pharmacological options are also available; however, they are not explicitly approved for PCOS treatment as they have been primarily used to treat other conditions such as T2DM

This description comes directly from the study's public registry record.

Talk to the study team

ahmed hussein, phD  ·  01001749605  ·  ahmedhussein.med@o6u.edu.eg

ahmed hussein  ·  ahmedhussein.med@o6u.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

October 6 university hospitalGiza, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06142656